LTβR-IN-1
LTβR-IN-1 is a selective lymphotoxin beta receptor (LTβR) inhibitor that blocks p52 nuclear translocation induced by ligands like TWEAK with an IC50 of 10 μM, without affecting TNF-α-mediated p65 translocation. This tool compound is used in vitro to study the non-canonical NF-κB pathway in immune regulation and lymphoid organogenesis.
Product Specifications
CAS Number
2189366-77-4
Product Name Alternative
LTbR-IN-1, LTbetaR-IN-1, LTR, LTβR IN 1, LTβR, p52 translocation, LTβRIN1, LTβR-IN-1, NF-κB, NFκB, NF-kB, NFkB
Field of Research
Immunology & Inflammation, Signal Transduction
Purity
98.83% (May vary between batches)
Solubility
DMSO:113 mg/mL (352.74 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (12.49 mM)
Smiles
C[C@@H] (N1Cc2ccccc2C1=O) C (=O) Nc1nc2ccccc2[nH]1
Molecular Formula
C18H16N4O2
Molecular Weight
320.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human CPT2 shRNA (UAS) - Lentiviral human CPT2 shRNA (UAS, RFP) plasmid
